AI assistant
OMNICELL, INC. — Director's Dealing 2017
Aug 8, 2017
31980_dirs_2017-08-08_e7616913-efad-439c-b1a6-8c5f496a75b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OMNICELL, Inc (OMCL)
CIK: 0000926326
Period of Report: 2017-08-07
Reporting Person: Taborga Jorge R. (Executive VP. Engineering)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-08-07 | Common Stock | S | 3257 | $50.80 | Disposed | 50013 | Direct |
| 2017-08-07 | Common Stock | M | 17462 | — | Acquired | 67475 | Direct |
| 2017-08-07 | Common Stock | S | 17462 | $51.0166 | Disposed | 50013 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-08-07 | Non-Qualified Option (right to buy) | $25.08 | M | 3282 | Acquired | 2024-02-04 | Common Stock (3282) | Direct |
| 2017-08-07 | Non-Qualified Option (right to buy) | $34.02 | M | 3515 | Acquired | 2025-02-06 | Common Stock (3515) | Direct |
| 2017-08-07 | Non-Qualified Option (right to buy) | $27.70 | M | 6803 | Acquired | 2026-02-04 | Common Stock (6803) | Direct |
| 2017-08-07 | Non-Qualified Option (right to buy) | $27.70 | M | 1362 | Acquired | 2026-02-06 | Common Stock (1362) | Direct |
| 2017-08-07 | Non-Qualified Option (right to buy) | $18.55 | M | 2500 | Acquired | 2023-03-05 | Common Stock (2500) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 53270 | Direct |
Footnotes
F1: The price reported in Column 4 is the average price of $51.0166. The shares sold between $50.50 to $51.125. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The price reported in Column 4 is the exact price of $50.80. All the shares sold for the exact price. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan.